Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents

Journal of the American College of Cardiology

Volumn 57, Issue 4, 2011, Pages 390-398

  Nakazawa, Gaku ^a   Finn, Aloke V ^b   Vorpahl, Marc ^a   Ladich, Elena R ^a   Kolodgie, Frank D ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bare metal stent(s); BMS; DES; drug eluting stent(s); late stent thrombosis; LST; paclitaxel eluting stent(s); PES; SES; sirolimus eluting stent(s)

Indexed keywords

FIBRIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RESPONSE; CORONARY STENT; DELAYED HYPERSENSITIVITY; DRUG ELUTING STENT; FEMALE; FIBRIN DEPOSITION; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NEOINTIMA; PRIORITY JOURNAL; STENT THROMBOSIS; THICKNESS;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSTHESIS FAILURE; REGISTRIES; RISK ASSESSMENT; SIROLIMUS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 78751623656     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.05.066     Document Type: Article

References (34)

1. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
2. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
3. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
4. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
5. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662
6. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
7. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
8. G. Nakazawa, A.V. Finn, and M. Joner Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
9. L.G. Luna Histologic Staining Methods of the Armed Forces Institute of Pathology 1968 McGraw-Hill New York, NY
10. C.L. Grines, R.O. Bonow, and D.E. Casey Jr. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians Circulation 115 2007 813 818
11. O.C. Marroquin, F. Selzer, and S.R. Mulukutla A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med 358 2008 342 352
12. G. Nakazawa, A.V. Finn, and E. Ladich Drug-eluting stent safety: findings from preclinical studies Expert Rev Cardiovasc Ther 6 2008 1379 1391
13. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
14. A. Farb, P.F. Heller, and S. Shroff Pathological analysis of local delivery of paclitaxel via a polymer-coated stent Circulation 104 2001 473 479
15. A.W. Heldman, L. Cheng, and G.M. Jenkins Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis Circulation 103 2001 2289 2295
16. J. Ako, Y. Morino, and Y. Honda Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis J Am Coll Cardiol 46 2005 1002 1005
17. K. Tanabe, P.W. Serruys, and M. Degertekin Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial Circulation 111 2005 900 905
18. S. Cook, P. Wenaweser, and M. Togni Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434
19. A.K. Hassan, S.C. Bergheanu, and T. Stijnen Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis Eur Heart J 31 2010 1172 1180
20. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
21. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
22. A.V. Finn, F.D. Kolodgie, and J. Harnek Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2005 270 278
23. M. Takano, M. Yamamoto, and D. Murakami Lack of association between large angiographic late loss and low risk of in-stent thrombus: angioscopic comparison between paclitaxel- and sirolimus-eluting stents Circ Cardiovasc Interv 1 2008 20 27
24. A. Farb, F.D. Kolodgie, and J.Y. Hwang Extracellular matrix changes in stented human coronary arteries Circulation 110 2004 940 947
25. T. Kimura, H. Yokoi, and Y. Nakagawa Three-year follow-up after implantation of metallic coronary-artery stents N Engl J Med 334 1996 561 566
26. J. Aoki, A.C. Abizaid, and P.W. Serruys Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients J Am Coll Cardiol 46 2005 1670 1676
27. J. Aoki, A. Colombo, and D. Dudek Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study Circulation 112 2005 3876 3883
28. M.C. Morice, P.W. Serruys, and P. Barragan Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 2007 1299 1304
29. J.E. Sousa, M.A. Costa, and A. Abizaid Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents Circulation 111 2005 2326 2329
30. T. Ishida, and K. Tanaka Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture Atherosclerosis 44 1982 161 174
31. M. Naito, C.M. Stirk, E.B. Smith, and W.D. Thompson Smooth muscle cell outgrowth stimulated by fibrin degradation products The potential role of fibrin fragment E in restenosis and atherogenesis Thromb Res 98 2000 165 174
32. G.J. Wilson, G. Nakazawa, and R.S. Schwartz Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries Circulation 120 2009 141 149 12
33. V. Kumar, A. Abbas, N. Fausto, and R. Mitchell Robbins Basic Pathology 8th edition 2007 Elsevier Science Philadelphia, PA
34. A. Farb, D.K. Weber, F.D. Kolodgie, A.P. Burke, and R. Virmani Morphological predictors of restenosis after coronary stenting in humans Circulation 105 2002 2974 2980